Hypertensive patients with Raynaud's phenomenon or intermittent claudication and their treatment with ketanserin.

Suppr

超能文献

作者信息

van Oene J C

机构信息

Department of Clinical Research, Janssen Pharmaceutica B.V., Tilburg, The Netherlands.

出版信息

Drugs. 1988;36 Suppl 1:148-51. doi: 10.2165/00003495-198800361-00030.

DOI:10.2165/00003495-198800361-00030

PMID:3240729

Abstract

摘要

相似文献

Hypertensive patients with Raynaud's phenomenon or intermittent claudication and their treatment with ketanserin.

Drugs. 1988;36 Suppl 1:148-51. doi: 10.2165/00003495-198800361-00030.

Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.

Angiology. 1989 Feb;40(2):114-21. doi: 10.1177/000331978904000206.

Effect of chronic ketanserin treatment on serotonin-induced platelet aggregation in patients with Raynaud's phenomenon.慢性酮色林治疗对雷诺现象患者血清素诱导的血小板聚集的影响。

Eur J Clin Pharmacol. 1990;39(3):289-90. doi: 10.1007/BF00315113.

Left atrial myxoma presenting with intermittent claudication and Raynaud's phenomenon: echocardiographic patterns of the tumor size.以间歇性跛行和雷诺现象为表现的左心房黏液瘤：肿瘤大小的超声心动图表现

Angiology. 1979 May;30(5):356-60. doi: 10.1177/000331977903000510.

Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.酮色林对进行性系统性硬化症中雷诺现象的影响：一项双盲试验。

Drugs Exp Clin Res. 1985;11(9):659-63.

Ketanserin versus nifedipine in secondary Raynaud's phenomenon.

Vasa. 1987;16(1):77-80.

Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenon.酮色林治疗与原发性和继发性雷诺现象患者的血清素

Eur J Clin Pharmacol. 1988;35(4):419-21. doi: 10.1007/BF00561375.

[Treatment of Raynaud's phenomenon].[雷诺现象的治疗]

Ann Dermatol Venereol. 1987;114(8):1035-8.

Comparative efficacy of ketanserin and pentoxiphylline in treatment of Raynaud's phenomenon.酮色林与己酮可可碱治疗雷诺现象的疗效比较

Angiology. 1989 Jul;40(7):633-8. doi: 10.1177/000331978904000705.

[Treatment of Raynaud's syndrome with ketanserin. Clinical, biological and hemodynamic aspects].[用酮色林治疗雷诺综合征。临床、生物学和血液动力学方面]

Presse Med. 1987;16(27):1335.

引用本文的文献

Oral dosing with ketanserin to control high blood pressure in the elderly.口服酮色林以控制老年人的高血压。

Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:111-4. doi: 10.1007/BF00053440.

Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.酮色林。对其药效学和药代动力学特性以及在高血压和外周血管疾病中的治疗潜力的综述。

Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010.

本文引用的文献

Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.用酮色林治疗结缔组织病患者的雷诺现象。

Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):577-9. doi: 10.1136/bmj.289.6445.577.

5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.5-羟色胺、α-肾上腺素能受体与血压。酮色林在原发性高血压和自主神经功能不全中的作用。

Hypertension. 1984 Jan-Feb;6(1):100-9. doi: 10.1161/01.hyp.6.1.100.

Comparison of ketanserin and metoprolol in the treatment of essential hypertension.

Arch Intern Med. 1987 Feb;147(2):291-6.

Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy.通过99锝高锝酸盐闪烁扫描评估动脉内给予酮色林对雷诺现象的影响。

Eur J Clin Pharmacol. 1988;34(3):267-71. doi: 10.1007/BF00540954.

Serum cholesterol during ketanserin and propranolol administration in hypertensive patients.高血压患者服用酮色林和普萘洛尔期间的血清胆固醇

J Cardiovasc Pharmacol. 1987 Dec;10(6):647-50. doi: 10.1097/00005344-198712000-00007.

Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.

J Cardiovasc Pharmacol. 1987 Jun;9(6):728-33.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验